Thomas Starkey, Maria C Ionescu, Michael Tilby, Martin Little, Emma Burke, Matthew W Fittall, Sam Khan, Justin K H Liu, James R Platt, Rosie Mew, Arvind R Tripathy, Isabella Watts, Sophie Therese Williams, Nathan Appanna, Youssra Al-Hajji, Matthew Barnard, Liza Benny, Alexander Burnett, Jola Bytyci, Emma L Cattell, Vinton Cheng, James J Clark, Leonie Eastlake, Kate Gerrand, Qamar Ghafoor, Simon Grumett, Catherine Harper-Wynne, Rachel Kahn, Alvin J X Lee, Oliver Lomas, Anna Lydon, Hayley Mckenzie, Hari Panneerselvam, Jennifer S Pascoe, Grisma Patel, Vijay Patel, Vanessa A Potter, Amelia Randle, Anne S Rigg, Tim M Robinson, Rebecca Roylance, Tom W Roques, Stefan Rozmanowski, René L Roux, Ketan Shah, Remarez Sheehan, Martin Sintler, Sanskriti Swarup, Harriet Taylor, Tania Tillett, Mark Tuthill, Sarah Williams, Yuxin Ying, Andrew Beggs, Tim Iveson, Siow Ming Lee, Gary Middleton, Mark Middleton, Andrew Protheroe, Tom Fowler, Peter Johnson, Lennard Y W Lee
Patients with cancer are at increased risk of hospitalisation and mortality following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, the SARS-CoV-2 phenotype evolution in patients with cancer since 2020 has not previously been described. We therefore evaluated SARS-CoV-2 on a UK populationscale from 01/11/2020-31/08/2022, assessing case-outcome rates of hospital assessment(s), intensive care admission and mortality. We observed that the SARS-CoV-2 disease phenotype has become less severe in patients with cancer and the non-cancer population...
July 25, 2023: Scientific Reports